The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 41

More JCP Articles

JCP
Impact of Major Depressive Disorder on Comorbidities
Systematic Review

October 19, 2022

Associations between major depressive disorder (MDD) and comorbid disorders have been studied, but not all have been explored systematically. This study summarized observational data on the effect of MDD…
, , , et al
JCP
Relationship Between MDD and Medical Conditions
Commentary

October 19, 2022

This commentary by Rachel A. Weir, MD, and Mark Hyman Rapaport, MD, discusses the article by Alix M. Arnaud, MSc, and colleagues on the overlap between major depressive disorder…
,
JCP
Acceptability of Second-Line Antidepressant Medications
Original Research

October 17, 2022

Second-line antidepressant options were ranked according to acceptability (efficacy and tolerability), using data from the French health system.
, , , et al
JCP
Lost in Translation: The Value of Psychiatric Clinical Trials
Commentary

October 17, 2022

John C. Markowitz, MD, and Barbara L. Milrod, MD, assert the value of clinical trials in psychiatry and outline reasons why NIMH should resume supporting them.
,
JCP
Living in a Pharmacologically Imperfect World
Editorial

October 12, 2022

Joseph F. Goldberg, MD, comments on prescription of valproate in women of reproductive potential, and the risk-benefit analysis involved with choosing the least imperfect treatment option.
JCP
Valproate Prescribing in Individuals of Childbearing Age
Letter to the Editor

October 12, 2022

Camille Tastenhoye, MD, and colleagues share data from a tertiary care women’s hospital that highlight opportunities for improvement in valproate prescribing practices.
, , , et al
JCP
Addressing the Problem of Prescription of Valproate to Women of Childbearing Age: Reply to Tastenhoye et al
Letter to the Editor

October 12, 2022

Chittaranjan Andrade, MD, responds to a letter by Tastenhoye et al and comments on his recent study on valproate prescription in women.
JCP
Prescribing Guideline for Valproic Acid and Women of Reproductive Potential: Forget It Exists
Editorial

October 12, 2022

Marlene P. Freeman, MD, outlines reasons not to prescribe valproic acid in women of reproductive potential.
JCP
Antidepressant Discontinuation Syndrome Resulting in a Suicide Attempt
Case Report

October 10, 2022

The authors report on a patient who attempted suicide after discontinuing antidepressant treatment and experiencing associated “electric shocks” and other symptoms.
,
JCP
Economic Burden of Schizophrenia in the US
Original Research

October 10, 2022

Schizophrenia is associated with significant economic burden, not only for patients but also for families, other caregivers, and the wider society. This study analyzed recent data and literature to…
, , , et al
JCP
Frontothalamic Circuit Abnormalities in Patients With Bipolar Disorder and Suicide Attempts
Original Research

October 5, 2022

To identify potential markers for suicide risk, this fMRI study looked at neural activity in bipolar depression patients with and without suicide attempts and in healthy controls.
, , , et al
JCP
Fear Learning, Extinction Learning, and Reversal Learning in OCD
Systematic Review

October 5, 2022

Alterations in fear learning, extinction learning, and reversal learning are key processes in OCD. This review summarizes the research and its applications for optimizing OCD treatment.
,

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe